Alkeus Pharmaceuticals, Inc. is a clinical-stage biotech company focused on the development of innovative therapies to treat serious diseases of the eye with high unmet need. Based in Cambridge, Mass., Alkeus was founded in 2010, and since that time has been developing its lead compound, gildeuretinol acetate (ALK-001). Designated as a breakthrough therapy and granted orphan drug status by the U.S. Food and Drug Administration, gildeuretinol is being evaluated in multiple clinical trials for the treatment of Stargardt disease and geographic atrophy (GA) secondary to age-related macular degeneration (AMD), a leading cause of blindness in the U.S.
Pick a job to read the details
Tap any role on the left — its description and apply link will open here.
Share this job
Alkeus Pharmaceuticals, Inc. is a clinical-stage biotech company focused on the development of innovative therapies to treat serious diseases of the eye with high unmet need. Based in Cambridge, Mass., Alkeus was founded in 2010, and since that time has been developing its lead compound, gildeuretinol acetate (ALK-001). Designated as a breakthrough therapy and granted orphan drug status by the U.S. Food and Drug Administration, gildeuretinol is being evaluated in multiple clinical trials for the treatment of Stargardt disease and geographic atrophy (GA) secondary to age-related macular degeneration (AMD), a leading cause of blindness in the U.S.
Position Summary:
The Senior Director, Commercial Strategy lead is responsible for understanding the evolving needs of the Stargardt community and shaping the brand strategy, including the execution of comprehensive marketing plans. This role will lead brand planning, product launches, and lifecycle management, working closely with cross-functional teams across commercial, medical, regulatory, and clinical functions.
This is a leadership role on the commercial team that will own the go-to-market strategy, lifecycle planning, ensuring seamless collaboration across functions and support market access research ultimately driving meaningful patient impact and delivering strong business results.
Primary Responsibilities:
Brand Strategy & Tactical Execution:
Competitive Strategy and Response:
Program Team and key workstreams participation:
Qualifications:
Other Relevant Information:
Compensation
Alkeus Pharmaceuticals, Inc. is an equal opportunity employer and considers all qualified applicants for employment without regard to any characteristic protected by applicable law. We participate in E-Verify and conduct background checks as a part of our employment process.
Ready to apply?
Apply to Alkeus Pharmaceuticals
Share this job
Alkeus Pharmaceuticals, Inc. is a clinical-stage biotech company focused on the development of innovative therapies to treat serious diseases of the eye with high unmet need. Based in Cambridge, Mass., Alkeus was founded in 2010, and since that time has been developing its lead compound, gildeuretinol acetate (ALK-001). Designated as a breakthrough therapy and granted orphan drug status by the U.S. Food and Drug Administration, gildeuretinol is being evaluated in multiple clinical trials for the treatment of Stargardt disease and geographic atrophy (GA) secondary to age-related macular degeneration (AMD), a leading cause of blindness in the U.S.
Position Summary:
The Project Management/Analytics Intern will support the design of project dashboards, populating details and running analyses to identify key trends. They will work closely with a cross functional team to develop and implement a KOL planning tracker and an information source map. They will conduct research on topics related to Stargardt disease, inclusive of competition landscape and generate summary reports of their findings for the cross functional stakeholders. As a member of the team, they will support with planning meeting agendas, tracking activities and circulating
Primary Responsibilities:
Qualifications:
Compensation
#LI-DNI
Alkeus Pharmaceuticals, Inc. is an equal opportunity employer and considers all qualified applicants for employment without regard to any characteristic protected by applicable law. We participate in E-Verify and conduct background checks as a part of our employment process.
Ready to apply?
Apply to Alkeus Pharmaceuticals
Share this job
Alkeus Pharmaceuticals, Inc. is a clinical-stage biotech company focused on the development of innovative therapies to treat serious diseases of the eye with high unmet need. Based in Cambridge, Mass., Alkeus was founded in 2010, and since that time has been developing its lead compound, gildeuretinol acetate (ALK-001). Designated as a breakthrough therapy and granted orphan drug status by the U.S. Food and Drug Administration, gildeuretinol is being evaluated in multiple clinical trials for the treatment of Stargardt disease and geographic atrophy (GA) secondary to age-related macular degeneration (AMD), a leading cause of blindness in the U.S.
Position Summary:
The Senior Clinical Scientist is responsible for providing scientific leadership and oversight for late-stage (Phase 3) clinical development programs in rare disease ophthalmology. This role plays a critical part in ensuring the scientific integrity, regulatory readiness, and successful execution of pivotal clinical trials intended to support global registration.
As a senior individual contributor, the Senior Clinical Scientist serves as a core scientific partner across clinical development, working closely with clinical operations, biostatistics, regulatory affairs, and safety to translate strategy into executable, high-quality Phase 3 studies. This role is well-suited for an experienced hire with demonstrated success in late-stage clinical development within rare disease and/or ophthalmology.
Primary Responsibilities:
Deliver on other related projects and initiatives as assigned, with flexibility to support evolving program needs in a growing biotechnology environment.
Qualifications:
Other Relevant Information:
Compensation
Alkeus Pharmaceuticals, Inc. is an equal opportunity employer and considers all qualified applicants for employment without regard to any characteristic protected by applicable law. We participate in E-Verify and conduct background checks as a part of our employment process.
Ready to apply?
Apply to Alkeus Pharmaceuticals
Share this job
Alkeus Pharmaceuticals, Inc. is a clinical-stage biotech company focused on the development of innovative therapies to treat serious diseases of the eye with high unmet need. Based in Cambridge, Mass., Alkeus was founded in 2010, and since that time has been developing its lead compound, gildeuretinol acetate (ALK-001). Designated as a breakthrough therapy and granted orphan drug status by the U.S. Food and Drug Administration, gildeuretinol is being evaluated in multiple clinical trials for the treatment of Stargardt disease and geographic atrophy (GA) secondary to age-related macular degeneration (AMD), a leading cause of blindness in the U.S.
Position Summary
The Clinical Trial Manager (CTM) is responsible for the execution, and oversight of global clinical trials, ensuring high-quality delivery in alignment with ICH-GCP, regulatory requirements, and corporate objectives. This role provides day-to-day operational management of CROs and vendors and contributes to the development of processes that support the growth of the Clinical Operations function. This position requires on site presence in the Alkeus office in Cambridge, MA.
Responsibilities
Qualifications
Other Relevant Information:
Compensation
Alkeus Pharmaceuticals, Inc. is an equal opportunity employer and considers all qualified applicants for employment without regard to any characteristic protected by applicable law. We participate in E-Verify and conduct background checks as a part of our employment process.
Ready to apply?
Apply to Alkeus Pharmaceuticals
Share this job
Alkeus Pharmaceuticals, Inc. is a clinical-stage biotech company focused on the development of innovative therapies to treat serious diseases of the eye with high unmet need. Based in Cambridge, Mass., Alkeus was founded in 2010, and since that time has been developing its lead compound, gildeuretinol acetate (ALK-001). Designated as a breakthrough therapy and granted orphan drug status by the U.S. Food and Drug Administration, gildeuretinol is being evaluated in multiple clinical trials for the treatment of Stargardt disease and geographic atrophy (GA) secondary to age-related macular degeneration (AMD), a leading cause of blindness in the U.S.
We are seeking a people focused and accomplished leader to join our team as Vice President, Clinical Operations to lead and expand the company’s clinical operations capabilities supporting clinical programs in retinal diseases.
Position Summary
The Vice President, Clinical Operations role is a key leadership position responsible for the strategic planning, execution, and oversight of global clinical trials, with particular focus on Phase 3 and other late-stage studies.
This individual plays a critical role in ensuring operational excellence across the clinical development portfolio, including the successful delivery of pivotal clinical trials supporting global regulatory filings. The Vice President will lead and mentor a clinical operations team, collaborate cross-functionally across the R&D organization, and oversee external partners to ensure clinical studies are executed efficiently, ethically, and in full compliance with regulatory standards and Good Clinical Practice (GCP).
As a senior leader in R&D, this individual contributes to clinical development strategy and cross-functional planning while representing Clinical Operations internally with leadership and externally with investigators, CRO partners, and other clinical stakeholders.
Primary Responsibilities
Qualifications
Other Relevant Information:
Compensation
Alkeus Pharmaceuticals, Inc. is an equal opportunity employer and considers all qualified applicants for employment without regard to any characteristic protected by applicable law. We participate in E-Verify and conduct background checks as a part of our employment process.
Ready to apply?
Apply to Alkeus Pharmaceuticals
Share this job
Alkeus Pharmaceuticals, Inc. is a clinical-stage biotech company focused on the development of innovative therapies to treat serious diseases of the eye with high unmet need. Based in Cambridge, Mass., Alkeus was founded in 2010, and since that time has been developing its lead compound, gildeuretinol acetate (ALK-001). Designated as a breakthrough therapy and granted orphan drug status by the U.S. Food and Drug Administration, gildeuretinol is being evaluated in multiple clinical trials for the treatment of Stargardt disease and geographic atrophy (GA) secondary to age-related macular degeneration (AMD), a leading cause of blindness in the U.S.
We are looking for enthusiastic professionals who want to be at the forefront of our mission and make a significant impact on the growth and direction of Alkeus Pharmaceuticals.
We invite you to apply and submit your resume for general consideration.
#LI-DNI
Alkeus Pharmaceuticals, Inc. is an equal opportunity employer and considers all qualified applicants for employment without regard to any characteristic protected by applicable law. We participate in E-Verify and conduct background checks as a part of our employment process.
Ready to apply?
Apply to Alkeus Pharmaceuticals
Cookies & analytics
This site uses cookies from third-party services to deliver its features and to analyze traffic.